Documentation Centre

August 26, 2020
Lipoprotein (a): An update on a marker of residual risk and associated clinical manifestations. Am J Cardiol. 2020;126:94-102.
Shah NP, Pajidipati NJ, McGarrah RW, Navar AM, Vemulapalli S, Blazing MA, Shah SH, Hernandez AF, Patel MR

Description of this Publication

Consult publication on external website

By clicking on this link, you will leave the INTERNATIONAL CHAIR ON CARDIOMETABOLIC RISK website

Key Words
Cardiometabolic Risk, Cardiovascular Disease, Lipids/Lipoproteins